Sarah Ketterer - Causeway Capital Management
Holding/activity history for Glaxosmithkline Plc (AP47)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2022 Q2 | 0 | 0.00 | Sell 100.00% | 0.27 | SEC | ||
| 2022 Q1 | 258,378 | 0.27 | Add 44.71% | 0.08 | $43.56 | $11,255,000 | SEC |
| 2021 Q4 | 178,546 | 0.17 | Buy | 0.17 | $44.10 | $7,874,000 | SEC |
| 2019 Q2 | 0 | 0.00 | Sell 100.00% | <0.01 | SEC | ||
| 2019 Q1 | 1,423 | <0.01 | Reduce 99.50% | 0.13 | $41.46 | $59,000 | SEC |
| 2018 Q4 | 284,591 | 0.13 | Reduce 27.02% | 0.05 | $38.21 | $10,874,000 | SEC |
| 2018 Q3 | 389,980 | 0.17 | Reduce 9.00% | 0.02 | $40.17 | $15,665,000 | SEC |
| 2018 Q2 | 428,526 | 0.19 | Reduce 53.46% | 0.23 | $40.31 | $17,274,000 | SEC |
| 2018 Q1 | 920,777 | 0.43 | Add 46.12% | 0.14 | $39.07 | $35,975,000 | SEC |
| 2017 Q4 | 630,163 | 0.27 | Add 14.39% | 0.03 | $35.47 | $22,352,000 | SEC |
| 2017 Q3 | 550,910 | 0.28 | Add 29.61% | 0.06 | $40.60 | $22,367,000 | SEC |
| 2017 Q2 | 425,047 | 0.25 | Add 34.72% | 0.06 | $43.12 | $18,328,000 | SEC |
| 2017 Q1 | 315,515 | 0.20 | Add 7.11% | 0.01 | $42.16 | $13,302,000 | SEC |
| 2016 Q4 | 294,560 | 0.19 | Reduce 10.04% | 0.03 | $37.50 | $11,047,000 | SEC |
| 2016 Q3 | 327,419 | 0.26 | Reduce 0.72% | <0.01 | $43.13 | $14,122,000 | SEC |
| 2016 Q2 | 329,801 | 0.31 | Reduce 26.78% | 0.12 | $43.34 | $14,294,000 | SEC |
| 2016 Q1 | 450,405 | 0.45 | Reduce 13.10% | 0.06 | $42.91 | $19,327,000 | SEC |
| 2015 Q4 | 518,275 | 0.44 | Reduce 14.52% | 0.07 | $40.35 | $20,912,000 | SEC |
| 2015 Q3 | 606,315 | 0.47 | Add 19.44% | 0.08 | $38.45 | $23,313,000 | SEC |
| 2015 Q2 | 507,631 | 0.53 | Add 15.47% | 0.07 | $41.65 | $21,143,000 | SEC |
| 2015 Q1 | 439,614 | 0.53 | Buy | 0.53 | $46.15 | $20,288,000 | SEC |
| 2009 Q3 | 0 | 0.00 | Sell 100.00% | 0.01 | SEC | ||
| 2009 Q1 | 235 | 0.01 | Reduce 99.86% | 7.41 | $29.79 | $7,000 | SEC |
| 2008 Q4 | 165,003 | 7.42 | Add 70,114.04% | 7.41 | $9.59 | $1,582,000 | SEC |
| 2008 Q3 | 235 | 0.01 | Buy | 0.01 | $42.55 | $10,000 | SEC |